Funds › Perkins Capital Management Inc
Perkins Capital Management Inc
13F for Q3 2026, filed Nov 2, 2026. 87 positions worth $140.0M.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of Perkins Capital Management Inc in the latest 13F quarter?
Using 13F.ai, how has Perkins Capital Management Inc's portfolio concentration changed over the last four quarters?
Using 13F.ai, which of Perkins Capital Management Inc's top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q3 2026
Largest first. Common shares only; puts and calls are under All positions.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | NTRA Natera, Inc. | 40,380 | $16.7M | 11.9% | -0.6% | 13F ↗ |
| 2 | LLY Eli Lilly and Company | 8,680 | $10.0M | 7.2% | Unchanged | 13F ↗ |
| 3 | AMD Advanced Micro Devices, Inc. | 13,404 | $8.2M | 5.9% | -3.6% | 13F ↗ |
| 4 | BFLY Butterfly Network, Inc. | 858,580 | $7.7M | 5.5% | -1.0% | 13F ↗ |
| 5 | AXGN Axogen, Inc. | 145,842 | $6.1M | 4.4% | -1.4% | 13F ↗ |
| 6 | MSFT Microsoft Corporation | 11,173 | $5.7M | 4.1% | Unchanged | 13F ↗ |
| 7 | IDXX IDEXX Laboratories, Inc. | 9,700 | $5.1M | 3.6% | Unchanged | 13F ↗ |
| 8 | PSNL Personalis, Inc. | 230,000 | $3.7M | 2.7% | -3.8% | 13F ↗ |
| 9 | OOMA Ooma, Inc. | 176,970 | $3.6M | 2.6% | Unchanged | 13F ↗ |
| 10 | CYRX CryoPort, Inc. | 198,547 | $3.5M | 2.5% | -0.7% | 13F ↗ |
| 11 | BLZE Backblaze, Inc. | 202,035 | $2.8M | 2.0% | -34.6% | 13F ↗ |
| 12 | QUIK QuickLogic Corporation | 244,146 | $2.8M | 2.0% | -5.2% | 13F ↗ |
| 13 | VCYT Veracyte, Inc. | 59,958 | $2.8M | 2.0% | Unchanged | 13F ↗ |
| 14 | MGNI Magnite, Inc. | 98,375 | $2.5M | 1.8% | -0.3% | 13F ↗ |
| 15 | TELA TELA Bio, Inc. | 2.08M | $2.4M | 1.7% | +51.4% | 13F ↗ |
| 16 | NEOG Neogen Corporation | 177,500 | $2.3M | 1.6% | Unchanged | 13F ↗ |
| 17 | CIEN Ciena Corporation | 6,300 | $2.2M | 1.6% | Unchanged | 13F ↗ |
| 18 | ZETA Zeta Global Holdings Corp. | 69,225 | $2.2M | 1.6% | +23.8% | 13F ↗ |
| 19 | LMAT LeMaitre Vascular, Inc. | 25,345 | $2.1M | 1.5% | Unchanged | 13F ↗ |
| 20 | ABT Abbott Laboratories | 20,257 | $2.0M | 1.4% | Unchanged | 13F ↗ |
| 21 | NEO NeoGenomics, Inc. | 108,040 | $2.0M | 1.4% | -1.8% | 13F ↗ |
| 22 | ATEC Alphatec Holdings, Inc. | 183,905 | $1.9M | 1.4% | +5.0% | 13F ↗ |
| 23 | BDSX Biodesix, Inc. | 61,335 | $1.8M | 1.3% | +37.5% | 13F ↗ |
| 24 | GLOO Gloo Holdings, Inc. | 410,000 | $1.8M | 1.3% | New | 13F ↗ |
| 25 | CSTL Castle Biosciences, Inc. | 49,315 | $1.8M | 1.3% | +206% | 13F ↗ |
| 26 | MASS 908 Devices Inc. | 135,050 | $1.7M | 1.2% | New | 13F ↗ |
| 27 | PERI Perion Network Ltd | 165,215 | $1.4M | 1.0% | Unchanged | 13F ↗ |
| 28 | CDXS Codexis, Inc. | 1.02M | $1.4M | 1.0% | +94.2% | 13F ↗ |
| 29 | ABBV AbbVie Inc. | 5,307 | $1.4M | 1.0% | Unchanged | 13F ↗ |
| 30 | TLSI TriSalus Life Sciences, Inc. | 297,991 | $1.3M | 0.9% | +26.8% | 13F ↗ |
| 31 | CXDO Crexendo, Inc. | 212,825 | $1.3M | 0.9% | Unchanged | 13F ↗ |
| 32 | MDXG MiMedx Group, Inc | 260,500 | $1.2M | 0.9% | New | 13F ↗ |
| 33 | SSYS Stratasys, Ltd. | 138,250 | $1.1M | 0.8% | New | 13F ↗ |
| 34 | MRK Merck & Company, Inc. | 7,500 | $1.1M | 0.8% | Unchanged | 13F ↗ |
| 35 | GILD Gilead Sciences, Inc. | 7,216 | $1.1M | 0.8% | Unchanged | 13F ↗ |
| 36 | SPAI Safe Pro Group Inc. | 223,000 | $1.0M | 0.7% | -3.3% | 13F ↗ |
| 37 | ATRC AtriCure, Inc. | 17,400 | $977.9K | 0.7% | -0.6% | 13F ↗ |
| 38 | PFE Pfizer, Inc. | 33,759 | $962.8K | 0.7% | Unchanged | 13F ↗ |
| 39 | AVEX AEVEX Corp. | 63,575 | $962.5K | 0.7% | New | 13F ↗ |
| 40 | VTRS Viatris Inc. | 50,087 | $887.5K | 0.6% | -7.0% | 13F ↗ |
| 41 | AAPL Apple Inc. | 2,650 | $882.5K | 0.6% | Unchanged | 13F ↗ |
| 42 | LUCD Lucid Diagnostics Inc. | 1.13M | $844.9K | 0.6% | Unchanged | 13F ↗ |
| 43 | FOCL Edap Tms S A · ADR | 183,000 | $818.0K | 0.6% | New | 13F ↗ |
| 44 | CREX Creative Realities, Inc. | 299,550 | $760.9K | 0.5% | -0.2% | 13F ↗ |
| 45 | MDXH MDxHealth SA | 1.29M | $752.3K | 0.5% | -8.9% | 13F ↗ |
| 46 | TGT Target Corporation | 4,750 | $744.3K | 0.5% | Unchanged | 13F ↗ |
| 47 | USB U.S. Bancorp | 12,350 | $713.3K | 0.5% | Unchanged | 13F ↗ |
| 48 | USIO Usio, Inc. | 264,000 | $710.2K | 0.5% | -62.3% | 13F ↗ |
| 49 | MRNA Moderna, Inc. | 3,500 | $674.0K | 0.5% | -12.5% | 13F ↗ |
| 50 | BLNE Beeline Holdings, Inc. | 781,200 | $656.2K | 0.5% | +228% | 13F ↗ |
Changes since Q2 2026
12 new, 15 added to, 27 trimmed, 4 exited, 33 unchanged. By estimated dollars.
New positions (12)
| GLOO Gloo Holdings, Inc. | 410,000 | New | $1.8M |
| MASS 908 Devices Inc. | 135,050 | New | $1.7M |
| MDXG MiMedx Group, Inc | 260,500 | New | $1.2M |
| SSYS Stratasys, Ltd. | 138,250 | New | $1.1M |
| AVEX AEVEX Corp. | 63,575 | New | $962.5K |
| FOCL Edap Tms S A · ADR | 183,000 | New | $818.0K |
| CDNA CareDx, Inc. | 6,000 | New | $390.0K |
| IONQ IonQ, Inc. | 5,806 | New | $254.7K |
| ANIP ANI Pharmaceuticals, Inc. | 3,366 | New | $244.5K |
| P Everpure, Inc. | 1,750 | New | $228.9K |
Added to (15)
| CSTL Castle Biosciences, Inc. | 49,315 | +206% | $1.2M |
| TELA TELA Bio, Inc. | 2.08M | +51.4% | $813.5K |
| CDXS Codexis, Inc. | 1.02M | +94.2% | $689.1K |
| BDSX Biodesix, Inc. | 61,335 | +37.5% | $498.7K |
| BLNE Beeline Holdings, Inc. | 781,200 | +228% | $456.3K |
| ZETA Zeta Global Holdings Corp. | 69,225 | +23.8% | $420.7K |
| TLSI TriSalus Life Sciences, Inc. | 297,991 | +26.8% | $271.1K |
| CATX Perspective Therapeutics, Inc. | 51,200 | +181% | $90.8K |
| ATEC Alphatec Holdings, Inc. | 183,905 | +5.0% | $89.9K |
| OWLT Owlet, Inc. | 116,075 | +9.0% | $50.4K |
Trimmed (27)
| BLZE Backblaze, Inc. | 202,035 | -34.6% | -$1.5M |
| USIO Usio, Inc. | 264,000 | -62.3% | -$1.2M |
| AMD Advanced Micro Devices, Inc. | 13,404 | -3.6% | -$305.9K |
| INUV Inuvo, Inc. | 92,294 | -82.1% | -$238.1K |
| QUIK QuickLogic Corporation | 244,146 | -5.2% | -$153.1K |
| PSNL Personalis, Inc. | 230,000 | -3.8% | -$146.5K |
| MRNA Moderna, Inc. | 3,500 | -12.5% | -$96.3K |
| NTRA Natera, Inc. | 40,380 | -0.6% | -$93.0K |
| NMTC NeuroOne Medical Technologies Corporation | 159,854 | -34.7% | -$87.3K |
| AXGN Axogen, Inc. | 145,842 | -1.4% | -$83.8K |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
All positions
Search, sort and filter every position, with puts and calls on their own tab. Premium plan.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q3 2026.
Filings
| Filing | ||||||
|---|---|---|---|---|---|---|
| Q3 2026 | Nov 2, 2026 | 13F-HR | 87 | $140.0M | Current | SEC ↗ |
| Q2 2026 | Jul 24, 2026 | 13F-HR | 79 | $133.0M | Current | SEC ↗ |
| Q1 2026 | Apr 23, 2026 | 13F-HR | 86 | $106.7M | Current | SEC ↗ |
| Q4 2025 | Feb 4, 2026 | 13F-HR | 91 | $125.9M | Current | SEC ↗ |
| Q3 2025 | Oct 31, 2025 | 13F-HR | 83 | $113.5M | Current | SEC ↗ |
| Q2 2025 | Aug 7, 2025 | 13F-HR | 83 | $99.5M | Current | SEC ↗ |
| Q1 2025 | May 7, 2025 | 13F-HR | 82 | $94.8M | Current | SEC ↗ |
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer